We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Repros Asks FDA to Lift Hold, Plans Safety Study for Proellex
Repros Asks FDA to Lift Hold, Plans Safety Study for Proellex
April 14, 2010
Repros Therapeutics has requested that the FDA lift a full clinical hold on Proellex, its uterine fibroids and endometriosis drug candidate.